Legal & General Group PLC Cytokinetics Inc Transaction History
Legal & General Group PLC
- $390 Billion
- Q2 2025
A detailed history of Legal & General Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 181,737 shares of CYTK stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,737
Previous 177,881
2.17%
Holding current value
$11.6 Million
Previous $7.15 Million
16.02%
% of portfolio
0.0%
Previous 0.0%
Shares
35 transactions
Others Institutions Holding CYTK
# of Institutions
385Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.12 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$933 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$762 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$498 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$405 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.99B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...